The author discusses how x-ray spectrometry can be an effective way to measure these impurities and meet regulatory guidelines.
In sufficiently high concentrations, elemental impurities, typically from catalyst residue, can pose safety risks. The author discusses how x-ray spectrometry can be an effective way to measure these impurities and meet regulatory guidelines.
Read this articlefrom Pharmaceutical Technology’s 2016 Solid Dosage Drug Development and Manufacturing eBook.
View other articles in the
2016 Solid Dosage Drug Development and Manufacturing eBook.UK Medicines Manufacturing Skills Centre Stresses Skill Development after Budget Announcement
November 8th 2024A £520 million investment for manufacturing capacity was announced by Chancellor of the Exchequer, Rachel Reeves, but academic and industry leaders stress the money should be used to train personnel.